Having moderate to severe diabetic retinopathy before starting the medication A history of poorly controlled blood sugar over many years High blood pressure that is not well managed Kidney disease or other diabetes-related complications Very rapid reduction in hemoglobin A1C levels within the first few months Rare cases of sudden, painless vision loss from optic nerve injury have been reported in people using GLP-1 receptor agonists
The program includes ongoing support, regular check-ins, and medication adjustments to help you stay on track
Doctronics AI doctor uses the latest medical research to provide clear, personalized answers about Mucinex and other medicines
GLP-1s are safe and effective for most people in the short to medium term, but we dont have long-term data to be sure theyre not causing severe adverse effects elsewhere.
For example, a starter dose of Novo's Ozempic is 0.25 milligrams
doi:10.1038/ejcn.2014.266 Gonzalez JT, Stevenson EJ